InvestorsHub Logo
Followers 56
Posts 8436
Boards Moderated 0
Alias Born 05/14/2015

Re: None

Monday, 04/18/2022 8:24:05 AM

Monday, April 18, 2022 8:24:05 AM

Post# of 118365
Fact: The FDA has no currently approved INDs on file for REGEN. REGEN and its partner ONPH have yet to file anything on the licensed patent.

Regen's only approved IND lapsed with the FDA and is no longer is valid. After several refiles due to lacking data (the problem with having poor management) Regen finally got HemaX approved to start the FDA Clinical trial process and proceed to Phase 1 trials.

The problem was that Koos had no funding to put together the expensive Phase 1 trail which tests for safety.

The critical step was the death knell for HemaX.

So what did Konman Koos do? He abandoned it and decided to focus on DCellVax.

He tried submitting it to the FDA but the FDA, once again, kicked the submission back because Regen failed to provided the minimum data needed. Koos then hired Dr. Kesari to help with the submission. Even Dr. Kesari help was not enough as the FDA still wanted more info before giving DCELLVAX the nod for approval to start the clinical phase testing.

Bad management = bad results and Koos is one bad CEO.

That's a fact and still a fact today.

And patents don't equal guaranteed success or a cure for cancer.

If it did, why then has no one of significance come to help fund Regen in a legit way to get the drugs into the testing phase?

REGEN is just another OTC SCAM stock run by one guy who has used the loose OTC policies to enrich himself while he has screwed over his investors, partners, and vendors.

Just ask Chemdiv. Koos had to pay them $800K to avoid getting his clock cleaned in court.

FACTS are stubborn things